<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35496718</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1178-2390</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>15</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Journal of multidisciplinary healthcare</Title>
          <ISOAbbreviation>J Multidiscip Healthc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Relationship Between Peripartum Cardiomyopathy and Preeclampsia - Pathogenesis, Diagnosis and Management.</ArticleTitle>
        <Pagination>
          <StartPage>857</StartPage>
          <EndPage>867</EndPage>
          <MedlinePgn>857-867</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2147/JMDH.S357872</ELocationID>
        <Abstract>
          <AbstractText>Peripartum cardiomyopathy (PPCM) is a condition with an incompletely understood etiology, although many risk factors for this disorder have been mentioned. Preeclampsia (PE) is a rare but undoubtedly very important cause of PPCM. Early recognition and prompt treatment of preeclampsia and peripartum cardiomyopathy are essential to optimize pregnancy outcomes. An extensive manual search of major electronic databases was conducted in November 2021. The following literature review provides a comprehensive discussion of peripartum cardiomyopathy and preeclampsia and quantifies the prevalence of PE in women with PPCM. The authors highlighted aspects such as epidemiology, risk factors, cardiovascular changes, diagnosis and clinical presentation, and management and complications. Accumulating data indicate that both conditions have a similar pathogenesis characterized by vascular abnormalities. In both conditions we can observe an increase in interleukin-6 and gamma interferon, CCL2/MCP1, and decreased SOD activity. sFLT1 (a soluble form of fms-like tyrosine kinase 1), a substance with antiangiogenic and probably cardiotoxic effects, may be important. Preeclampsia and peripartum cardiomyopathy are characterized by recurrence rates that follow a similar pattern in subsequent pregnancies, and mortality remains a concern. Our analysis highlights the need to better understand the co-morbidity of PE and PPCM, and the need to qualify patients for the same clinical trials because of the common origin of these conditions.</AbstractText>
          <CopyrightInformation>© 2022 Kuć et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kuć</LastName>
            <ForeName>Aleksandra</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-3634-1347</Identifier>
            <AffiliationInfo>
              <Affiliation>Student Research Group at the Chair and Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kubik</LastName>
            <ForeName>Daria</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0002-3588-5764</Identifier>
            <AffiliationInfo>
              <Affiliation>Student Research Group at the Chair and Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kościelecka</LastName>
            <ForeName>Klaudia</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-6694-8182</Identifier>
            <AffiliationInfo>
              <Affiliation>Student Research Group at the Chair and Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Szymanek</LastName>
            <ForeName>Wojciech</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0001-6515-7699</Identifier>
            <AffiliationInfo>
              <Affiliation>Hospital Emergency Department, St. John Paul II Mazovia Regional Hospital in Siedlce, Siedlce, Poland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Nursing at Collegium Mazovia Innovative University in Siedlce, Siedlce, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Męcik-Kronenberg</LastName>
            <ForeName>Tomasz</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0002-0618-8265</Identifier>
            <AffiliationInfo>
              <Affiliation>Chair and Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Zabrze, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Multidiscip Healthc</MedlineTA>
        <NlmUniqueID>101512691</NlmUniqueID>
        <ISSNLinking>1178-2390</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PE</Keyword>
        <Keyword MajorTopicYN="N">PPCM</Keyword>
        <Keyword MajorTopicYN="N">conditions</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
      </KeywordList>
      <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>53</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35496718</ArticleId>
        <ArticleId IdType="pmc">PMC9045831</ArticleId>
        <ArticleId IdType="doi">10.2147/JMDH.S357872</ArticleId>
        <ArticleId IdType="pii">357872</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. JAMA. 2000;283(9):1183–1188. doi:10.1001/jama.283.9.1183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.283.9.1183</ArticleId>
            <ArticleId IdType="pubmed">10703781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94:311–316. doi:10.1016/s0029-7844(99)00293-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0029-7844(99)00293-8</ArticleId>
            <ArticleId IdType="pubmed">10432149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of the European society of cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–778. doi:10.1093/eurjhf/hfq120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hfq120</ArticleId>
            <ArticleId IdType="pubmed">20675664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–2055. doi:10.1161/01.CIR.0000162478.36652.7E</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.0000162478.36652.7E</ArticleId>
            <ArticleId IdType="pubmed">15851613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polskie Towarzystwo Kardiologiczne. Guidelines of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH); 2018. Available from: https://ptkardio.pl/wytyczne/1-wytyczne_escesh_dotyczace_postepowania_w_nadcisnieniu_tetniczym. Accessed April
20, 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Hull E, Hidden E. Postpartal heart failure. South Med J. 1938;31:265–270. doi:10.1097/00007611-193803000-00010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00007611-193803000-00010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971;44(5):964–968. doi:10.1161/01.CIR.44.5.964</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.44.5.964</ArticleId>
            <ArticleId IdType="pubmed">4255967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gunderson EP, Croen LA, Chiang V, et al. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118:583–591. doi:10.1097/AOG.0b013e318229e6de</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0b013e318229e6de</ArticleId>
            <ArticleId IdType="pubmed">21860287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bauer ST, Cleary KL. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol. 2009;33(3):158–165. doi:10.1053/j.semperi.2009.02.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.semperi.2009.02.008</ArticleId>
            <ArticleId IdType="pubmed">19464506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parikh P, Blauwet L. Peripartum cardiomyopathy and preeclampsia: overlapping diseases of pregnancy. Curr Hypertens Rep. 2018;20(8):69. doi:10.1007/s11906-018-0868-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11906-018-0868-9</ArticleId>
            <ArticleId IdType="pubmed">29971645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–304. doi:10.1016/j.amjcard.2007.02.092</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjcard.2007.02.092</ArticleId>
            <ArticleId IdType="pubmed">17631087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolte D, Khera S, Aronow WS, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3(3):e001056. doi:10.1161/JAHA.114.001056</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.114.001056</ArticleId>
            <ArticleId IdType="pmc">PMC4309108</ArticleId>
            <ArticleId IdType="pubmed">24901108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fett JD, Carraway RD, Dowell DL, et al. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol. 2002;186:1005–1010. doi:10.1067/mob.2002.122423</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mob.2002.122423</ArticleId>
            <ArticleId IdType="pubmed">12015528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mielniczuk LM, Williams K, Davis DR. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765–1768. doi:10.1016/j.amjcard.2006.01.039</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjcard.2006.01.039</ArticleId>
            <ArticleId IdType="pubmed">16765131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnamoorthy P, Garg J, Palaniswamy C, et al. and outcomes of peripartum cardiomyopathy in the United States: findings from the Nationwide Inpatient Sample. J Cardiovasc Med. 2016;17(10):756–761. doi:10.2459/JCM.0000000000000222</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2459/JCM.0000000000000222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu VC, Chen TH, Yeh JK, et al. Clinical outcomes of peripartum cardiomyopathy: a 15-year nationwide population-based study in Asia. Medicine. 2017;96(43):e8374. doi:10.1097/MD.0000000000008374</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000008374</ArticleId>
            <ArticleId IdType="pmc">PMC5671863</ArticleId>
            <ArticleId IdType="pubmed">29069030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barasa A, Rosengren A, Sandström TZ, et al. Heart failure in late pregnancy and postpartum: incidence and long-term mortality in Sweden from 1997 to 2010. J Card Fail. 2017;23(5):370–378. doi:10.1016/j.cardfail.2016.12.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardfail.2016.12.011</ArticleId>
            <ArticleId IdType="pubmed">28069474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Cho GJ, Park GU, et al. Incidence, risk factors, and clinical characteristics of peripartum cardiomyopathy in South Korea. Circ Heart Fail. 2018;11(4):e004134. doi:10.1161/CIRCHEARTFAILURE.117.004134</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.117.004134</ArticleId>
            <ArticleId IdType="pubmed">29626099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melamed N, Ray JG, Hladunewich M, et al. Gestational hypertension and preeclampsia: are they the same disease?
J Obstet Gynaecol Can. 2014;36(7):642–647. doi:10.1016/S1701-2163(15)30545-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1701-2163(15)30545-4</ArticleId>
            <ArticleId IdType="pubmed">25184984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bello N, Rendon ISH, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:1715–1723. doi:10.1016/j.jacc.2013.08.717</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2013.08.717</ArticleId>
            <ArticleId IdType="pmc">PMC3931606</ArticleId>
            <ArticleId IdType="pubmed">24013055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Mebazaa A, Hilfiker-Kleiner D, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): eurobservational research programme in conjunction with the heart failure association of the European society of cardiology study group on PPCM. Eur J Heart Fail. 2017;19(9):1131–1141. doi:10.1002/ejhf.780</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.780</ArticleId>
            <ArticleId IdType="pubmed">28271625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reuwer AQ, Reuwer PJ, van der Post JA, et al. Twickler Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia. Med Hypotheses. 2010;74:348–352. doi:10.1016/j.mehy.2009.08.029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mehy.2009.08.029</ArticleId>
            <ArticleId IdType="pubmed">19748190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5(1):173–192. doi:10.1146/annurev-pathol-121808-102149</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-pathol-121808-102149</ArticleId>
            <ArticleId IdType="pubmed">20078220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333–338. doi:10.1038/nature11040</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11040</ArticleId>
            <ArticleId IdType="pmc">PMC3356917</ArticleId>
            <ArticleId IdType="pubmed">22596155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fett JD. Peripartum cardiomyopathy: a puzzle closer to solution. World J Cardiol. 2014;6(3):87–99. doi:10.4330/wjc.v6.i3.87</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4330/wjc.v6.i3.87</ArticleId>
            <ArticleId IdType="pmc">PMC3964190</ArticleId>
            <ArticleId IdType="pubmed">24669290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen KA, Gniady K, Lelonek M. Peripartum cardiomyopathy — still unknown Current State of Knowledge. Folia Cardiologica. 2019;14:305–314. doi:10.5603/FC.2019.0064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5603/FC.2019.0064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63:346–352. doi:10.1161/HYPERTENSIONAHA.113.01787</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.01787</ArticleId>
            <ArticleId IdType="pubmed">24166751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel PA, Hernandez AF. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy. Eur J Heart Fail. 2013;15:724–729. doi:10.1093/eurjhf/hft065</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hft065</ArticleId>
            <ArticleId IdType="pmc">PMC3707431</ArticleId>
            <ArticleId IdType="pubmed">23639780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC151901</ArticleId>
            <ArticleId IdType="pubmed">12618519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–891. doi:10.1161/01.RES.0000147365.86159.f5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.0000147365.86159.f5</ArticleId>
            <ArticleId IdType="pubmed">15472115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rana S, Hacker MR, Modest AM, et al. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012;60(2):451–458. doi:10.1161/HYPERTENSIONAHA.112.195065</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.112.195065</ArticleId>
            <ArticleId IdType="pmc">PMC3432569</ArticleId>
            <ArticleId IdType="pubmed">22753210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor BD, Ness RB, Klebanoff MA, et al. First and second trimester immune biomarkers in pre-eclamptic and normotensive women. Pregnancy Hypertens. 2016;6(4):388–393. doi:10.1016/j.preghy.2016.09.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.preghy.2016.09.002</ArticleId>
            <ArticleId IdType="pmc">PMC5157692</ArticleId>
            <ArticleId IdType="pubmed">27939488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charkiewicz K, Jasinska E, Goscik J, et al. Angiogenic factor screening in women with mild preeclampsia—new and significant proteins in plasma. Cytokine. 2017;106:125–130. doi:10.1016/j.cyto.2017.10.020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2017.10.020</ArticleId>
            <ArticleId IdType="pubmed">29111087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaitu’u-Lino TJ, Brownfoot FC, Hastie R, et al. Activating transcription factor 3 is reduced in preeclamptic placentas and negatively regulates sFlt-1 (soluble fms-like tyrosine kinase 1), soluble endoglin, and proinflammatory cytokines in placenta. Hypertension. 2017;70(5):1014–1024. doi:10.1161/HYPERTENSIONAHA.117.09548</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.09548</ArticleId>
            <ArticleId IdType="pubmed">28947613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agachan B, Attar R, Isbilen E, et al. Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with preeclampsia. J Interf Cytokine Res. 2010;30(9):673–676. doi:10.1089/jir.2010.0008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jir.2010.0008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ricke-Hoch M, Bultmann I, Stapel B, et al. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res. 2014;101(4):587–596. doi:10.1093/cvr/cvu010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/cvu010</ArticleId>
            <ArticleId IdType="pubmed">24448315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American College of Obstetricians, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. doi:10.1097/01.AOG.0000437382.03963.88</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.AOG.0000437382.03963.88</ArticleId>
            <ArticleId IdType="pubmed">24150027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600. doi:10.1016/j.cell.2006.12.036</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2006.12.036</ArticleId>
            <ArticleId IdType="pubmed">17289576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blauwet LA, Cooper LT. Diagnosis and management of peripartum cardiomyopathy. Heart. 2011;97(23):1970–1981. doi:10.1136/heartjnl-2011-300349</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/heartjnl-2011-300349</ArticleId>
            <ArticleId IdType="pubmed">22058286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension. 1991;17(6 Pt 2):1072–1077. doi:10.1161/01.HYP.17.6.1072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.HYP.17.6.1072</ArticleId>
            <ArticleId IdType="pubmed">2045151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosio PM, McKenna PJ, Conroy R, et al. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94(6):978–984. doi:10.1016/s0029-7844(99)00430-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0029-7844(99)00430-5</ArticleId>
            <ArticleId IdType="pubmed">10576186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sibai BM, Mabie WC. Hemodynamics of preeclampsia. Clin Perinatol. 1991;18(4):727–747. doi:10.1016/S0095-5108(18)30493-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0095-5108(18)30493-7</ArticleId>
            <ArticleId IdType="pubmed">1764880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennis AT, Castro J, Carr C, et al. Haemodynamics in women with untreated pre-eclampsia. Anaesthesia. 2012;67(10):1105–1118. doi:10.1111/j.1365-2044.2012.07193.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2044.2012.07193.x</ArticleId>
            <ArticleId IdType="pubmed">22731876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Timpka S, Macdonald-Wallis C, Hughes AD, et al. Hypertensive disorders of pregnancy and offspring cardiac structure and function in adolescence. J Am Heart Assoc. 2016;5(11):e003906. doi:10.1161/JAHA.116.003906</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.116.003906</ArticleId>
            <ArticleId IdType="pmc">PMC5210338</ArticleId>
            <ArticleId IdType="pubmed">27799232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mutlu K, Karadas U, Yozgat Y, et al. Echocardiographic evaluation of cardiac functions in newborns of mildly preeclamptic pregnant women within postnatal 24–48 hours. J Obstet Gynaecol. 2018;38(1):16–21. doi:10.1080/01443615.2017.1322564</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01443615.2017.1322564</ArticleId>
            <ArticleId IdType="pubmed">28631496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ntusi NB, Badri M, Gumedze F, et al. Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One. 2015;10(8):e0133466. doi:10.1371/journal.pone.0133466</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0133466</ArticleId>
            <ArticleId IdType="pmc">PMC4529210</ArticleId>
            <ArticleId IdType="pubmed">26252951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindley KJ, Conner SN, Cahill AG, et al. Impact of preeclampsia on clinical and functional outcomes in women with peripartum cardiomyopathy. Circ Heart Fail. 2017;10(6):e003797. doi:10.1161/CIRCHEARTFAILURE.116.003797</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.116.003797</ArticleId>
            <ArticleId IdType="pmc">PMC5520674</ArticleId>
            <ArticleId IdType="pubmed">28572214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366. doi:10.1007/s00395-013-0366-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00395-013-0366-9</ArticleId>
            <ArticleId IdType="pmc">PMC3709080</ArticleId>
            <ArticleId IdType="pubmed">23812247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W, Li H, Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol. 2016;32(3):362–368. doi:10.1016/j.cjca.2015.07.733</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cjca.2015.07.733</ArticleId>
            <ArticleId IdType="pubmed">26586094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blauwet LA, Delgado-Montero A, Ryo K, et al. Right ventricular function in peripartum cardiomyopathy at presentation is associated with subsequent left ventricular recovery and clinical outcomes. Circ Heart Fail. 2016;9(5):e002756. doi:10.1161/CIRCHEARTFAILURE.115.002756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.115.002756</ArticleId>
            <ArticleId IdType="pubmed">27166247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haghikia A, Rontgen P, Vogel-Claussen J, et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study. ESC Heart Fail. 2015;2(4):139–149. doi:10.1002/ehf2.12059</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ehf2.12059</ArticleId>
            <ArticleId IdType="pmc">PMC5054874</ArticleId>
            <ArticleId IdType="pubmed">27774259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharyya A, Basra SS, Sen P, et al. Peripartum cardiomyopathy: a review. Tex Heart Inst J. 2012;39:8–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3298938</ArticleId>
            <ArticleId IdType="pubmed">22412221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44:1053–1061. doi:10.1161/01.cir.44.6.1053</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.cir.44.6.1053</ArticleId>
            <ArticleId IdType="pubmed">4256828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu YC, Huang ST, Ho ST, et al. An unusual case of peripartum cardiomyopathy in a parturient with preeclampsia. Acta Anaesthesiol Taiwan. 2010;48(1):33–36. doi:10.1016/S1875-4597(10)60007-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1875-4597(10)60007-0</ArticleId>
            <ArticleId IdType="pubmed">20434111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;130:860–870. doi:10.1016/0002-8703(95)90089-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-8703(95)90089-6</ArticleId>
            <ArticleId IdType="pubmed">7572598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–670. doi:10.1016/j.jacc.2011.03.047</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2011.03.047</ArticleId>
            <ArticleId IdType="pubmed">21816300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Fett JD, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368:687–693. doi:10.1016/S0140-6736(06)69253-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(06)69253-2</ArticleId>
            <ArticleId IdType="pubmed">16920474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;30(364):k5287. doi:10.1136/bmj.k5287</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.k5287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vázquez-Rodríguez JG, Veloz-Martínez MG. Pleural effusion and ascites in severe preeclampsia: frequency and correlation with plasma colloid osmotic pressure and renal filtration function. Cir Cir. 2011;79:299–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21951883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puri A, Sethi R, Singh B, et al. Peripartum cardiomyopathy presenting with ventricular tachycardia: a rare presentation. Indian Pacing Electrophysiol J. 2009;9:186–189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2683642</ArticleId>
            <ArticleId IdType="pubmed">19471599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gemici G, Tezcan H, Fak AS, et al. Peripartum cardiomyopathy presenting with repetitive monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2004;27:557–558. doi:10.1111/j.1540-8159.2004.00483.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1540-8159.2004.00483.x</ArticleId>
            <ArticleId IdType="pubmed">15078417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manikkan A, Sanati M. Peripartum cardiomyopathy presenting as splenic infarct. J Hosp Med. 2008;3(3):274–276. doi:10.1002/jhm.281</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jhm.281</ArticleId>
            <ArticleId IdType="pubmed">18571812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thangaratinam S, Gallos ID, Meah N, et al. TIPPS (tests in prediction of pre-eclampsia’s severity) review group how accurate are maternal symptoms in predicting impending complications in women with preeclampsia? a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90(6):564–573.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21355860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gestational Hypertension and. Preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260. doi:10.1097/AOG.0000000000003891</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000003891</ArticleId>
            <ArticleId IdType="pubmed">32443079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sperling JD, Dahlke JD, Huber WJ, et al. The role of headache in the classification and management of hypertensive disorders in pregnancy. Obstet Gynecol. 2015;126:297–302. doi:10.1097/AOG.0000000000000966</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000000966</ArticleId>
            <ArticleId IdType="pubmed">26241418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butalia S, Audibert F, Côté A-M, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34(5):3–526. doi:10.1016/j.cjca.2018.02.021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cjca.2018.02.021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toppenberg KS, Hill DA, Miller DP. Safety of radiographic imaging during pregnancy. Am Fam Physician. 1999;59:1813–1818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10208701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murali S, Baldisseri MR. Peripartum cardiomyopathy. Crit Care Med. 2005;33:S340–S346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16215357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zimmermann O, Kochs M, Zwaka TP, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol. 2005;104(1):92–100. doi:10.1016/j.ijcard.2005.02.052</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2005.02.052</ArticleId>
            <ArticleId IdType="pubmed">16137516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surdacki A, Bednarek J, Kruszelnicka O, et al. Przewlekła niewydolność serca (PNS). Medycyna Praktyczna; 2021. Available from: https://www.mp.pl/interna/chapter/B16.II.2.19.1.#74967. Accessed April
20, 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Marmursztejn J, Vignaux O, Goffinet F, et al. Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol. 2009;137(3):e63–4. doi:10.1016/j.ijcard.2009.04.028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2009.04.028</ArticleId>
            <ArticleId IdType="pubmed">19439378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mouquet F, Lions C, de Groote P, et al. Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol. 2008;18(12):2765–2769. doi:10.1007/s00330-008-1067-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-008-1067-x</ArticleId>
            <ArticleId IdType="pubmed">18642002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7:961–967. doi:10.1161/CIRCEP.114.001517</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCEP.114.001517</ArticleId>
            <ArticleId IdType="pubmed">25336366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ommen SR, Mital S, Burke MA, et al. American Heart Association. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2020;76(25):212.</Citation>
        </Reference>
        <Reference>
          <Citation>Jeejeebhoy FM, Zelop CM, Lipman S, et al. American heart association emergency cardiovascular care committee, council on cardiopulmonary, critical care, perioperative and resuscitation, council on cardiovascular diseases in the young, and council on clinical cardiology cardiac arrest in pregnancy: a scientific statement from the American heart association. Circulation. 2015;132(18):1747–1773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26443610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103(18):2254–2259. doi:10.1161/01.CIR.103.18.2254</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.103.18.2254</ArticleId>
            <ArticleId IdType="pubmed">11342473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–1315. doi:10.1016/j.ajog.2005.11.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajog.2005.11.008</ArticleId>
            <ArticleId IdType="pubmed">16647915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87(1023):34–39. doi:10.1136/pgmj.2009.096594</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/pgmj.2009.096594</ArticleId>
            <ArticleId IdType="pubmed">20935342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bozkurt B, Colvin M, Cook J, et al. American heart association committee on heart failure and transplantation of the council on clinical cardiology; council on cardiovascular disease in the young; council on cardiovascular and stroke nursing; council on epidemiology and prevention; and council on quality of care and outcomes research current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American heart association. Circulation. 2016;134(23):e579–e646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27832612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165–3241. doi:10.1093/eurheartj/ehy340</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehy340</ArticleId>
            <ArticleId IdType="pubmed">30165544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38(35):2671–2679. doi:10.1093/eurheartj/ehx355</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehx355</ArticleId>
            <ArticleId IdType="pmc">PMC5837241</ArticleId>
            <ArticleId IdType="pubmed">28934837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the heart failure association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096–1105. doi:10.1002/ejhf.586</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.586</ArticleId>
            <ArticleId IdType="pubmed">27338866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Velickovic IA, Leicht CH. Peripartum cardiomyopathy and cesarean section: report of two cases and literature review. Arch Gynecol Obstet. 2004;270(4):307–310. doi:10.1007/s00404-003-0568-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-003-0568-8</ArticleId>
            <ArticleId IdType="pubmed">14685890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canobbio MM, Warnes CA, Aboulhosn J, et al. American heart association council on cardiovascular and stroke nursing; council on clinical cardiology; council on cardiovascular disease in the young; council on functional genomics and translational biology; and council on quality of care and outcomes research management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American heart association. Circulation. 2017;135(8):e50–e87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28082385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol. 2011;58(4):337–350. doi:10.1016/j.jacc.2011.04.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2011.04.014</ArticleId>
            <ArticleId IdType="pubmed">21757110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140(5):785–791. doi:10.1067/mhj.2000.110091</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mhj.2000.110091</ArticleId>
            <ArticleId IdType="pubmed">11054626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fett JD, Sannon H, Thélisma E, et al. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet. 2009;104(2):125–127. doi:10.1016/j.ijgo.2008.09.017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijgo.2008.09.017</ArticleId>
            <ArticleId IdType="pubmed">19036370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaméogo NV, Kaboré E, Seghda A, et al. Embolie pulmonaire grave et ischémie aiguë de membre inférieur compliquant une cardiomyopathie du péripartum traitées avec succès par thrombolyse à la streptokinase [Severe pulmonary embolism and acute lower limb ischemia complicating peripartum cardiomyopathy successfully treated by streptokinase]. Ann Cardiol Angeio. 2016;65(1):38–41. French.</Citation>
        </Reference>
        <Reference>
          <Citation>Abdulbaki A, Kocherla C, Modi K. Aspiration thrombectomy in a case of acute myocardial infarction due to coronary emboli in a patient with peripartum cardiomyopathy and mural thrombus. Heart Int. 2016;10:e25–7. doi:10.5301/heartint.5000225</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5301/heartint.5000225</ArticleId>
            <ArticleId IdType="pmc">PMC4946383</ArticleId>
            <ArticleId IdType="pubmed">27672434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kharwar RB, Chandra S, Dwivedi SK, et al. A pedunculated left ventricular thrombus in a women with peripartum cardiomyopathy: evaluation by three dimensional echocardiography. J Cardiovasc Ultrasound. 2014;22(3):139–143. doi:10.4250/jcu.2014.22.3.139</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4250/jcu.2014.22.3.139</ArticleId>
            <ArticleId IdType="pmc">PMC4192412</ArticleId>
            <ArticleId IdType="pubmed">25309691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US
Department of health and human services. Available from: http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed August
30, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Skudicky D, Bergemann A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35(3):701–705. doi:10.1016/S0735-1097(99)00624-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0735-1097(99)00624-5</ArticleId>
            <ArticleId IdType="pubmed">10716473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark SJ, Kahn K, Houle B, et al. Young children’s probability of dying before and after their mother’s death: a rural South African population-based surveillance study. PLoS Med. 2013;10(3):e1001409. doi:10.1371/journal.pmed.1001409</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1001409</ArticleId>
            <ArticleId IdType="pmc">PMC3608552</ArticleId>
            <ArticleId IdType="pubmed">23555200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fett JD, Murphy JG. Infant survival in Haiti after maternal death from peripartum cardiomyopathy. Int J Gynaecol Obstet. 2006;94(2):135–136. doi:10.1016/j.ijgo.2006.05.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijgo.2006.05.009</ArticleId>
            <ArticleId IdType="pubmed">16828765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J. 2011;75(8):1975–1981. doi:10.1253/circj.CJ-10-1214</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1253/circj.CJ-10-1214</ArticleId>
            <ArticleId IdType="pubmed">21617320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barasa A, Goloskokova V, Ladfors L, et al. Symptomatic recovery and pharmacological management in a clinical cohort with peripartum cardiomyopathy. J Matern Fetal Neonatal Med. 2018;31(10):1342–1349. doi:10.1080/14767058.2017.1317341</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14767058.2017.1317341</ArticleId>
            <ArticleId IdType="pubmed">28462600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seeho SK, Algert CS, Roberts CL, et al. Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated. Am J Obstet Gynecol. 2016;215(6):785.e1–785.e8. doi:10.1016/j.ajog.2016.07.038</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajog.2016.07.038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Codsi E, Rose CH, Blauwet LA. Subsequent pregnancy outcomes in patients with peripartum cardiomyopathy. Obstet Gynecol. 2018;131(2):322–327. doi:10.1097/AOG.0000000000002439</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000002439</ArticleId>
            <ArticleId IdType="pubmed">29324614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guldbrandt Hauge M, Johansen M, Vejlstrup N, et al. Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study. BJOG. 2018;125(8):1018–1025. doi:10.1111/1471-0528.15046</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1471-0528.15046</ArticleId>
            <ArticleId IdType="pubmed">29211333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heider AL, Kuller JA, Strauss RA, et al. Peripartum cardiomyopathy: a review of the literature. Obstet Gynecol Surv. 1999;54(8):526–531. doi:10.1097/00006254-199908000-00023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006254-199908000-00023</ArticleId>
            <ArticleId IdType="pubmed">10434273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–1571. doi:10.1056/NEJM200105243442101</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM200105243442101</ArticleId>
            <ArticleId IdType="pubmed">11372007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avila WS, de Carvalho ME, Tschaen CK, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol. 2002;79(5):484–493. doi:10.1590/S0066-782X2002001400006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0066-782X2002001400006</ArticleId>
            <ArticleId IdType="pubmed">12447499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the heart failure association of the European society of cardiology study group on peripartum cardiomyopathy. Eur J Heart Fail. 2018;20(6):951–962. doi:10.1002/ejhf.1178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.1178</ArticleId>
            <ArticleId IdType="pubmed">29578284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Heart Association (AHA). Classes of heart failure; 2017. Available from: https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/classes-of-heart-failure. Accessed April
20, 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Förster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27(4):441–446. doi:10.1093/eurheartj/ehi481</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehi481</ArticleId>
            <ArticleId IdType="pubmed">16143707</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
